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Research Article

Molecular cause and functional impact of altered
synaptic lipid signaling due to a prg-1 gene SNP
Johannes Vogt1,*,†, Jenq-Wei Yang2,†, Arian Mobascher3,†, Jin Cheng1, Yunbo Li1, Xingfeng Liu1,
Jan Baumgart1, Carine Thalman1, Sergei Kirischuk2, Petr Unichenko2, Guilherme Horta1,
Konstantin Radyushkin4, Albrecht Stroh1, Sebastian Richers1, Nassim Sahragard1, Ute Distler4,5,
Stefan Tenzer5, Lianyong Qiao1, Klaus Lieb3, Oliver Tüscher3, Harald Binder6, Nerea Ferreiros7,
Irmgard Tegeder7, Andrew J Morris8, Sergiu Gropa9, Peter Nürnberg10, Mohammad R Toliat10,
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Abstract

DOI 10.15252/emmm.201505677 | Received 25 July 2015 | Revised 12 November
2015 | Accepted 12 November 2015 | Published online 15 December 2015

Loss of plasticity-related gene 1 (PRG-1), which regulates synaptic
phospholipid signaling, leads to hyperexcitability via increased
glutamate release altering excitation/inhibition (E/I) balance in
cortical networks. A recently reported SNP in prg-1 (R345T/
mutPRG-1) affects ~5 million European and US citizens in a
monoallelic variant. Our studies show that this mutation leads to a
loss-of-PRG-1 function at the synapse due to its inability to control
lysophosphatidic acid (LPA) levels via a cellular uptake mechanism
which appears to depend on proper glycosylation altered by
this SNP. PRG-1+/ mice, which are animal correlates of human
PRG-1+/mut carriers, showed an altered cortical network function
and stress-related behavioral changes indicating altered resilience
against psychiatric disorders. These could be reversed by modulation of phospholipid signaling via pharmacological inhibition of the
LPA-synthesizing molecule autotaxin. In line, EEG recordings in a
human population-based cohort revealed an E/I balance shift in
monoallelic mutPRG-1 carriers and an impaired sensory gating,
which is regarded as an endophenotype of stress-related mental
disorders. Intervention into bioactive lipid signaling is thus a
promising strategy to interfere with glutamate-dependent symptoms in psychiatric diseases.
Keywords bioactive phospholipids; cortical network; PRG-1; psychiatric
disorders; synapse
Subject Categories Genetics, Gene Therapy & Genetic Disease; Neuroscience
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Introduction
Accurate synaptic transmission is a fundamental requirement for
normal brain function (Turrigiano, 2011), and signaling alterations
at the excitatory synapse have been related to psychiatric disorders
such as schizophrenia (Harrison & Weinberger, 2005; Coyle, 2006;
Belforte et al, 2010). Recent research shows that bioactive lipid
signaling and protein–lipid interaction play major roles in all steps
of endo- and exocytosis processes, including synaptic vesicle
cycling (Di Paolo et al, 2004). Plasticity-related gene 1 (PRG-1, also
assigned as LPPR4), a neuron-specific molecule in the brain, is an
important postsynaptic control element of this pathway (Trimbuch
et al, 2009). Previously, we demonstrated that the absence of
PRG-1 (Brauer et al, 2003), which is involved in synaptic phospholipid signaling, leads to hippocampal hyperexcitability via increased
glutamate release at the synapse (Trimbuch et al, 2009). Recently,
a single nucleotide polymorphism (SNP, rs138327459, NHLBI
Exome Sequencing Project https://esp.gs.washington.edu/drupal/)
was detected in humans resulting in an arginine (R) to threonine
(T) exchange at position 345 of the amino acid chain (mouse
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homolog located at position 346). Our electrophysiological studies
using re-expression of PRG-1R346T in PRG-1 / mice by in utero
electroporation revealed that this mutation results in a loss-of-PRG-1
function at the synapse. On a molecular level, we could show
that PRG-1R346T lacked the ability to support uptake of lysophosphatidic acid (LPA) into intracellular compartments due to altered
O-glycosylation of S347 next to the SNP site, while in-depth quantitative analysis revealed no role for serine phosphorylation at this
position. PRG-1 heterozygous mice which are an animal correlate
for human monoallelic PRG-1+/mut carriers showed altered cortical
information processing and stress-related behavioral deficits indicative for mental disorders. Using specific inhibitors of phospholipid
synthesis, we could show that modulation of bioactive phospholipid levels upstream of PRG-1 reverted cortical network function
and behavior toward wild-type (wt) levels. In line with experimental data, electrophysiological assessment using the P50 sensory
gating auditory paradigm (which corresponds to the pre-pulse inhibition (PPI) tested in mice) revealed an altered sensory gating in
monoallelic R345T PRG-1 carriers which were identified among
1,811 human volunteers in a population-based cohort. Since similar
alterations of cortical excitability and sensory gating have been
described as an endophenotype of schizophrenia and stress-related
disorders (Turetsky et al, 2007; Javitt et al, 2008), our results indicate a novel therapeutic strategy targeting synaptic bioactive lipid
signaling in altered cortical information processing related to
mental disorders.

Results
PRG-1R346T is a loss-of-function mutation
PRG-1 was shown to be involved in internalization of lysophosphatidic acid (LPA) to intracellular postsynaptic compartments
(Trimbuch et al, 2009), thereby controlling LPA levels in the
synaptic cleft. To understand the molecular consequences of the
human SNP resulting in arginine (R) to threonine (T) exchange at
position 345 in the amino acid chain of PRG-1, we established
HEK cell lines with stable expression of the mouse homolog of
this SNP, PRG-1R346T, and found similar membrane localization
when compared to wild-type PRG-1 (wtPRG-1, Fig 1A). After
application of fluorescence labeled LPA (TopFluor (TF)-LPA) and
removal of surface bound TF-LPA using 0.001% SDS, PRG-1R346Texpressing cells displayed a lower fluorescence signal in intracellular compartments (Fig 1B). This finding was quantified by FACS
analysis (example shown in Fig 1C) revealing a significantly
reduced capacity of PRG-1R346T-expressing cells to internalize TFLPA when compared to wtPRG-1 (Fig 1D). To unambiguously
prove the internalization of LPA, we applied a chemically modified, unnatural LPA (C17-LPA) on wtPRG-1-expressing cells which
showed a statistically significant internalization of C17-LPA
(Fig 1E) and the intracellular presence of its metabolite C17-MAG
(Fig 1F) when compared to HEK cells which lack any PRG-1
expression. In line with previous results, PRG-1R346T-expressing
cells did not show a significant increase of intracellular C17 LPA
nor of its metabolite C17-MAG providing further evidence that
PRG-1R346T lacks the capacity to mediate internalization of LPA
into cells (Fig 1E and F).
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PRG-1R346T alters O-glycosylation, but not phosphorylation of
neighboring S347
Since PRG-1R346T was properly expressed at the membrane, we
hypothesized a posttranslational modification being involved in the
loss of function in TF-LPA internalization. Interestingly, the SNP
changing R345 (arginine) to 345T (threonine) is located in close
proximity to a frequently reported phosphorylation site (Munton
et al, 2007; Trinidad et al, 2008; Huttlin et al, 2010; Wisniewski
et al, 2010; Goswami et al, 2012). Therefore, we addressed the
question to what extent the neighboring S (serine) at position 346 in
humans and at position 347 in mouse is phosphorylated under wildtype conditions, and whether this phosphorylation is eventually
altered due to the mutation of R to T, which alters typical phosphorylation motifs (Pearson & Kemp, 1991). Using quantitative mass
spectrometry analysis and isotopically labeled peptides corresponding to the peptide containing S347, we detected that, although
described as a potential activity-related phosphorylation site
(Munton et al, 2007), S347 neighboring the SNP site showed only
minor phosphorylation (4.73% of total PRG-1, Fig 1G). In addition,
in PRG-1R346T, we could neither detect any relevant change in phosphorylation of S347 (3.33% of total PRG-1, Fig 1G), nor any phosphorylation of the T at position 346. To further assess whether S347
phosphorylation is a potential relevant cause for the loss of LPA
uptake of PRG-1R346T, we established HEK cell lines with a stable
expression of PRG-1S347A and PRG-1S347D, which either mimic the
non-phosphorylated (S347A) status or the phosphorylated status
(S347D) of S347. Both cell lines lacked the capacity to significantly
internalize TF-LPA above baseline levels (Fig 1H), strongly arguing
against an important role for phosphorylation explaining the loss of
function of PRG-1R346T in TF-LPA internalization, however, pointing
to the need of S347 at this position. Another intracellular posttranslational modification, critically important for brain function is
O-GlcNAC glycosylation (Rexach et al, 2008), which occurs at S and
T residues and has a complex interplay with phosphorylation
(Tarrant et al, 2012). Using immunoprecipitation studies and specific antibodies, we analyzed O-GlcNAC glycosylation in wtPRG-1 in
comparison with PRG-1R346T and detected significantly reduced
glycosylation levels in PRG-1R346T-expressing cells (Fig 1I and J),
indicating an interference of the R346T mutation with its neighboring S347 O-glycosylation site. Since neither A nor D is a target for
O-GlcNAC glycosylation and the cell lines expressing PRG-1S347A
and PRG-1S347D lacked the capacity of internalizing TF-LPA
(Fig 1H), these data point to the necessity of an O-glycosylation at S
for proper PRG-1 function, which is altered in PRG-1R346T.
In sum, these data on posttranslational modifications provide
evidence for the fact that not changes in phosphorylation, but
proper O-glycosylation of S at position 346 in humans interfered by
the R345T SNP is crucial for PRG-1 function.
PRG-1R346T is a loss-of-function mutation at the synapse
To analyze potential functional consequences of the human SNP in
neurons, we moved on in assessing PRG-1R346T function at the
synapse and performed whole-cell patch-clamp recordings from
layer IV spiny stellate neurons in the S1BF of PRG-1 / animals that
re-expressed PRG-1R346T delivered by in utero electroporation
(Fig 2A). This re-expression resulted in proper localization of
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Figure 1. PRG-1R346T: loss-of-function mutation reduced LPA internalization due to altered O-glycosylation.
A
B
C, D
E, F

G
H
I
J

PRG-1 and PRG-1R346T are expressed on HEK293 cell membranes.
Conventional fluorescence images of transfected and TopFluor (TF)-LPA-stimulated cells after washing with 0.001% SDS. Scale bar: 10 lm.
FACS analysis of internalized TF-LPA of PRG-1- and PRG-1R346T-transfected cells (n = 7 each, **P = 0.0015; t-test).
Incubation with C-17 LPA and subsequent washing as described above, led to a significant increase of TF-LPA in PRG-1-expressing cells but not in PRG-1R346Texpressing cells. In line, C-17 MG, a degradation product of C-17 LPA, was significantly increased in PRG-1-expressing cells but not in control or PRG-1R346Texpressing cells (n = 4 each; Kruskal–Wallis test (for C-17 LPA P = 0.0066; for C-17 MAG P = 0.0048) with Dunn’s multiple comparison test, *P < 0.05 for C-17 LPA
and C-17 MAG).
Quantitative assessment of S347 phosphorylation using isotopically labeled peptides and mass spectrometry of purified wild-type PRG-1 and PRG-1R346T from
stable transfected HEK293 cells revealed low total phosphorylation levels for both protein variants (n = 3 measurements).
TF-LPA uptake as analyzed by FACS was significantly decreased in S347A and S347D mutant PRG-1 (n = 12 per condition, ***P < 0.0001; one-way ANOVA with
Bonferroni’s multiple comparison test).
Western blot (WB) of IP using a specific PRG-1 antibody revealed decreased levels of O-GlcNAc in PRG-1R346T when compared to wild-type PRG-1.
Densitometric analysis of n = 7 WB from IP of PRG-1- and PRG-1R346T-expressing cells revealed a significantly decreased O-GlcNAc amount in PRG-1R346T (unpaired
t-test, *P = 0.0107).

Data information: All experiments were done in parallel. Bar diagrams represent mean  SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
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A, B In utero electroporation (IUE) of PRG-1
C, D In vitro whole-cell patch-clamp recordings from PRG-1 / layer IV spiny stellate neurons (S1BF) and of spiny stellate neurons reconstituted with PRG-1R346T by IUE.
Original traces are shown in (A) (n = 11 PRG-1 / neurons and 11 PRG-1R346T-reconstituted neurons from 4 mice; t-test).
E
Bright field image and regions of interest (ROIs, yellow) of primary neuronal cultures containing PRG-1 / neurons.
F
Detection of transfected neurons via a co-transfected IRES-GFP cassette by fluorescent illumination. Scale bar: 50 lm.
G
Baseline fluorescence (calculated as Df/f) of transfected and non-transfected neurons prior to TF-LPA stimulation.
H
PRG-1wt-transfected neurons displayed a clear increase in fluorescence intensity after TF-LPA application (left), while PRG-1R346T-transfected neurons were not
different from non-transfected PRG-1 / neurons (right).
I
Fluorescence intensity analysis of the ROIs revealed significant TF-LPA uptake in PRG-1wt-transfected neurons but not in PRG-1R346T-transfected neurons (n = 25
neurons per condition; repeated-measures ANOVA with Bonferroni post hoc correction, ***P < 0.0001).
J
Expression of GFP or of PRG-1R346T in wild-type neurons did not alter TF-LPA uptake when compared to non-transfected neurons (n = 57 wild-type, 10 GFPtransfected and 10 PRG-1R346T-transfected neurons; Kruskal–Wallis test with Dunn’s multiple comparison test).
K
Bright field image and fluorescence image overview showing TF-LPA in neurons with ROIs (yellow) of a primary neuronal culture.
L
Fluorescence analysis revealed a significantly lower TF-LPA uptake in PRG-1+/ neurons when compared to wild-type neurons (n = 15 neurons per group; unpaired
t-test, ***P < 0.0001).
Data information: Bar diagrams represent mean  SEM.
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PRG-1R346T protein at the spine head membrane, excluding an
impact of this mutation in protein targeting (Fig 2B). While reexpression of wtPRG-1 in PRG-1-deficient neurons was reported to
rescue the frequency of miniature excitatory postsynaptic currents
(mEPSC) to wild-type levels in hippocampal CA1 pyramidal cells
(Trimbuch et al, 2009), PRG-1R346T, albeit present at the proper
dendritic localization, failed to achieve this functional rescue. This
is consistent with a loss of function of PRG-1R346T, presumably due
to its inability to support LPA internalization (Fig 2A and C).
To directly assess the functional consequences of PRG-1R346T in
neurons in terms of their capacity to internalize LPA (Trimbuch et al,
2009), we used primary cortical neurons obtained from PRG-1 /
animals either transfected with a prg-1wt or with a prg-1R346T expressing construct (Fig 2E and F) and measured internalization of LPA
which was tagged by a fluorescence label (TopFluor, TF-LPA) in a
live imaging mode. TF-LPA internalization capacity of either PRG-1wt
or PRG-1R346T was compared to PRG-1-deficient neurons in the same
experiment (see also Fig 1G for baseline levels). To exclude bias by
the transfection procedure, we assessed the TF-LPA uptake capacity
of GFP-transfected PRG-1 / neurons finding no difference to the
non-transfected neurons (Fig EV1). While expression of PRG-1wt in
neurons induced a significant increase in TF-LPA internalization,
PRG-1R346T expression failed to do so (Fig 2H and I). To rule out a
dominant-negative effect of PRG-1R346T, we used the same approach
and transfected cortical neurons obtained from wild-type mice either
with a prg-1R346T or a control GFP construct and found no alteration
on TF-LPA-internalization in the transfected neurons (Fig 2J). These
studies confirmed that PRG-1R346T was a loss-of-function mutation in
a neuronal context. Finally, since the reported human SNP was only
detected in monoallelic carriers, we analyzed the impact of a monoallelic functional loss in cortical neurons obtained from PRG-1+/
animals and found that already monoallelic PRG-1 loss was sufficient
to significantly decrease TF-LPA-internalization when compared to
wild-type neurons (Fig 2K and L).
Altered phospholipid modulation due to monoallelic loss of
synaptic PRG-1 affects cortical E/I balance
In order to characterize the role of PRG-1 in cortical networks, we
assessed expression of PRG-1 in the cerebral cortex and found strong
expression in layer IV of the mouse somatosensory barrel field cortex
(S1BF; Fig 3A) which was restricted to glutamatergic neurons
(Fig EV2). Analysis of subcellular localization revealed that PRG-1
was expressed at dendritic spines (Fig 3B and C). Since heterozygous
deletion of PRG-1, leaving only one functional prg-1 allele, results in
a linear reduction of protein expression of approximately 50%
(Trimbuch et al, 2009), and heterozygous PRG-1-deficiency
significantly reduced the functional capacity of PRG-1+/ neurons to
internalize TF-LPA in a similar range (Fig 2K and L), PRG-1+/
animals are to be assumed as an animal correlate of human monoallelic PRG-1R345T carriers who only have one functional prg-1 allele
not affected by the mutation. To understand implications of such a
reduced synaptic PRG-1 function in intracortical information processing, we performed multichannel extracellular recordings in the S1BF
cortex of wt and PRG-1+/ mice in vivo (Fig 3D). Spontaneous activity analysis in PRG-1+/ mice showed a significant prolongation of
multiunit activity (MUA) burst duration when compared to wt mice
(Fig 3E and F). This finding points to a change in the cellular E/I
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balance toward excitation within cortical microcircuitries which has
been related to severe behavioral deficits (Yizhar et al, 2011).
Inhibition of LPA synthesis reverts altered cortical information
processing in monoallelic PRG-1-deficient mice
To test for involvement of phospholipids at the cortical network
level, we analyzed the effect of inhibiting the LPA-synthesizing
molecule autotaxin (ATX) which acts upstream of the LPA-LPA2/
PRG-1 axis (Moolenaar & Perrakis, 2011). HA-130, a recently
described specific inhibitor of ATX (Albers et al, 2010), significantly
decreased spontaneous postsynaptic currents (sPSC), which are the
sum of the overall excitatory and inhibitory input reflecting the total
E/I balance (Fig EV3). In line with these findings ex vivo, concentrations as low as 1 lM, HA 130, applied into the cortex of living
PRG-1+/ mice, significantly decreased the number of multiunit
activity (MUA) bursts (Fig 3G).
In addition to analysis of spontaneous cortical network activity,
we assessed pre-attentive cortical information processing and
measured sensory gating in a double-pulse whisker stimulation
model (Fig 4A). Local field potentials (recorded in the whiskerspecific cortical barrel) in response to repetitive single whisker stimulation elicited larger amplitudes to second stimulus in PRG-1+/
when compared to wt (S1; S2; ISI = 500 ms; Fig 4B). Larger S2
amplitudes altered S1–S2 values and resulted in a statistically significant increase of the S2/S1 ratio (Fig 4C and D). These findings indicate that already loss of one functional allele of prg-1 as present in
mutPRG-1 carriers, and thus a reduction of about 50% of functional
PRG-1 at the synapse, causes an apparent E/I imbalance in cortical
networks and an altered sensory gating. To prove whether phospholipid modulation is able to directly affect cortical information
processing, we applied HA-130 in the double-pulse whisker stimulation model (Fig 4E). This inhibition of LPA synthesis significantly
restored sensory gating in animals with monoallelic PRG-1deficiency as shown by reduction of S2 values (when compared to
S1 values) and a reduced S2/S1 ratio (Fig 4F and G).
Pharmacological intervention into monoallelic PRG-1 deficiency
reverts behavioral deficits characteristic for mental disorders
To answer the question whether observed alterations in excitatory
synaptic function and cortical network activity result in a behavioral phenotype, we assessed monoallelic PRG-1-deficient animals
(PRG-1+/ ). Using a three chambered box paradigm (Radyushkin
et al, 2009), we found a significantly reduced social interaction
index in PRG-1+/ mice (Figs 5A and EV4A). We further assessed
PRG-1+/ mice under normal conditions and after application of
environmental stress, known to be a risk factor for mental disorders
(van Winkel et al, 2008). While PRG-1+/ mice displayed no differences
under normal conditions in tail suspension tests, following acute
stress, PRG-1+/ mice showed a significantly higher immobility
(Fig 5B), indicative of alterations of resilient behaviors resembling
aspects of stress-related mental disorders (Cryan et al, 2005; Shen
et al, 2008; Inta et al, 2010).
Since reduced social interaction and altered behavior in tail
suspension test reflect symptoms of stress-related mental disorders
and alterations in resilient behaviors, we assessed pre-pulse inhibition (PPI) in these animals. PPI is highly conserved among
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Figure 3. PRG-1 expression in the somatosensory barrel field cortex (S1BF) and in vivo electrophysiological assessment.
A
PRG-1 is strongly expressed in layer IV neurons of the S1BF as shown by the b-Gal reporter. Scale bar: 100 lm.
B, C PRG-1 is localized on dendrites (B) and on MAP-2-positive spines (C). Scale bar: 5 lm.
D–F Cortical network assessment in PRG-1+/ mice as revealed by spontaneous MUA activity (spikes: lines; bursts: bars) analyzed in wt (11,379 bursts; five mice) and
PRG-1+/ (17,919 bursts; eight mice; unpaired t-test, ***P < 0.0001).
G
MUA burst numbers in PRG-1+/ mice before and after application of the ATX inhibitor HA-130 (n = 9, paired t-test, **P = 0.0053).
Data information: Bar diagrams represent mean  SEM.
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Figure 4. PRG-1+/ mice display an altered sensory gating which is rescued by ATX inhibition.
A–D Paired-pulse responses (500 ms ISI) to single whisker mechanical stimulation (trace show average of 30 responses) (A) and analysis of peak amplitudes (B), S1-S2
difference (C), and S2/S1 ratio (D) (Wilcoxon matched-pair signed rank test for wtS1 vs. wtS2, *P = 0.0137 and unpaired t-test for wtS2 vs. hetS2. *P = 0.0118 for B;
Mann-Whitney U-test was used for C and D, *P = 0.0446; n = 10 WT animals and 6 PRG-1 het animals.)
E
Paired-pulse responses before and after application of the ATX inhibitor HA-130.
F, G Peak amplitudes and S2/S1-ratio before and after ATX inhibition by HA-130 (n = 6 animals). Data comparing paired-pulse responses before and after application of
HA-130 were assessed by a one-tailed paired t-test (**P = 0.0093, *P = 0.0134).
Data information: Box plots represent the 25th and 75th percentile. The middle line shows the 50th percentile (median). Whiskers indicate the 10th and 90th percentiles.

vertebrates, is indicative for altered mental function, and is one of
few paradigms in which humans and rodents are tested in similar
fashions (Davis, 1984). Based on this, we studied PPI of the startle
response in PRG-1+/ (het) and wild-type (wt) mice finding that
PRG-1+/ animals showed a significant decrease of PPI in comparison with wt littermates (Fig 5C). To test whether pharmacological
treatment is able to revert these behavioral abnormalities indicative
for mental disorders, we tested an in vivo inhibitor of the
LPA-synthesizing enzyme autotaxin (PF8380) which has a nanomolar potency and can be applied orally or by injection to the periphery (Gierse et al, 2010). Intraperitoneal injection of PF8380
significantly diminished LPA levels in the cerebrospinal fluid
(Fig EV4B) and effectively restored the observed PPI deficit in freely
moving PRG-1+/ mice to wild-type levels (Fig 5C).
PRG-1R345T: a human SNP associated with an endophenotype for
mental disorders
Analysis of PRG-1 expression in the human cortex revealed strong
neuronal PRG-1 signals and a clear expression in layer IV neurons
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(Fig 6A). Using specific markers like GAD67, parvalbumin, and
calretinin, we found specific PRG-1 expression in glutamatergic
neurons but not in interneurons (Fig EV5A–C). Further subcellular
analysis revealed dendritic co-localization of PRG-1 with the postsynaptic density marker PSD95 (Fig 6B) confirming specific postsynaptic PRG-1 expression in glutamatergic synapses of excitatory
neurons as described in the rodent brain (Trimbuch et al, 2009).
To prove for the relevance of PRG-1 and its loss-of-function SNP
in humans, we analyzed a well-characterized sample of 1,811
healthy adult German subjects (Brinkmeyer et al, 2011; Lindenberg
et al, 2011; Quednow et al, 2012) (see Appendix Table S1 for
sociodemographic variables) where we detected the PRG-1R345T
(mutPRG-1) variant at a heterozygous frequency of 0.66% (12 carriers). EEG analysis of PRG-1+/mut carriers revealed alterations of the
P50 event-related cortical potential (ERP) elicited by an auditory
double-stimulus paradigm (stimulus 1 = S1, stimulus 2 = S2), a
measure of pre-attentive stimulus processing/sensory gating and an
endophenotype for mental disorders (Turetsky et al, 2007; Javitt
et al, 2008). PRG-1+/mut carriers showed larger P50 amplitudes in
response to the second stimulus (S2), a finding pointing to an
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Figure 5. PRG-1+/ mice display an endophenotype typical for psychiatric disorders which was rescued by ATX inhibition.
A The social interaction index was significantly reduced in PRG-1+/ (het) mice (n = 12 wild-type and 14 het mice; unpaired t-test, *P = 0.035).
B Tail suspension test under normal conditions and after exposure to acute restrain stress (n = 14 PRG-1 het and 12 wt animals; unpaired t-test, *P = 0.0214).
C PRG-1+/ mice displayed a robust deficit in PPI at all pre-pulse stimuli (*P = 0.0178). ATX inhibition via PF8380 treatment significantly rescued the PPI deficit in
PRG-1+/ mice to a level which was not different to the PPI measured in wt mice (n = 19 wt animals, 12 PRG-1 het animals, and 10 PRG-1 het animals + PF8380;
two-way ANOVA with Bonferroni post hoc, **P = 0.0068).
Data information: Bar diagrams represent mean  SEM.

excitation–inhibition imbalance and deficient “gating out” of redundant information (Chang et al, 2011) (Fig 6C). S1 reduction and S2
increase/diminished suppression may both contribute to sensory
gating abnormalities in mental disorders but have been considered
to reflect distinct/partially overlapping processes with a non-identical genetic architecture (Javitt et al, 2008; Chang et al, 2011).
Since PRG-1 is expressed in human excitatory neurons in the
somatosensory cortex (Figs 6A and B and EV5A–C), and PRG-1deficient mice (PRG-1 / ) display hippocampal hyperexcitability
(Trimbuch et al, 2009), the electrophysiological phenotype of human
PRG-1+/mut carriers suggested a functional alteration of mutPRG-1.
This apparently lead to an increased synaptic glutamate release at
excitatory neurons thus inducing a shift in the E/I balance toward
excitation (Yizhar et al, 2011) and an altered function of cortical
networks as observed in the pathophysiology of mental disorders
(Coyle, 2006; Belforte et al, 2010; Javitt et al, 2011).

Discussion
Bioactive lipid signaling at the synapse has only recently been
shown to be involved in the control of glutamatergic transmission.
Evidence from studies in hippocampal neurons highlights lysophosphatidic acid (LPA) as an active substance stimulating presynaptic
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LPA receptors which in turn control glutamate release from the
presynaptic terminal (Trimbuch et al, 2009). Synaptic LPA appears
to be under tight control of the postsynaptic lipid phosphatase-like
molecule PRG-1 (Brauer et al, 2003; McDermott et al, 2004), while
lack of PRG-1 and thus insufficient control of synaptic LPA action
result in overexcitation and eventually hippocampal epilepsy
(Trimbuch et al, 2009). We found that a single nucleotide polymorphism (SNP) in the human prg-1 gene resulting in a single amino
acid exchange (R345T in humans, mutPRG-1; homolog in mouse:
R346T) turned out to be a loss-of-function mutation of PRG-1. This
SNP with a monoallelic frequency of ~0.6% affects ~3.5 million
European and ~1.5 million US citizens and is homologous to the
SNP (rs138327459) reported by the NHLBI Exome Sequencing
Project (https://esp.gs.washington.edu/drupal/) in the isoform 2 of
PRG-1 (NP_001159724). Here, we analyzed the underlying molecular cause of this loss-of-function SNP and show that loss of
function of postsynaptic PRG-1 at the glutamatergic synapse leads
to an endophenotype (reduced sensory gating) described in
schizophrenia.
Phosphorylation is an important posttranslational modification of
synaptic proteins critically influencing their function (Lu & Roche,
2012). Since studies from different laboratories (Munton et al, 2007;
Trinidad et al, 2008; Huttlin et al, 2010; Wisniewski et al, 2010;
Goswami et al, 2012) have identified S347 as phosphorylation site in
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Figure 6. PRG-1 R345T: a loss-of-function human mutation induces an endophenotype for mental disorders.
A PRG-1 is expressed in NeuN-positive neurons of the somatosensory human cortex. Remark the PRG-1 expression delineating dendritic profiles of NeuN-positive
neurons. Insert depicts dendritic PRG-1 expression in a layer IV spiny stellate neuron at higher magnification. Scale bar: 100 lm.
B PRG-1 and PSD-95 punctae delineate dendritic profiles of a pyramidal neuron. Higher magnification (insert) exemplarily shows PRG-1/PSD95 co-localization (arrow
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C Stratified analysis of prg-1 genotype on P50 event-related potential in mutPRG-1 carriers.

PRG-1, which together with the preceding R346 forms a typical
phosphorylation motif (Pearson & Kemp, 1991), we have analyzed
the phosphorylation status of wild-type PRG-1 and PRG-1R346T. Interestingly, applying quantitative studies using isotopically labeled
peptides, we neither detected a biologically significant amount of
S347 phosphorylation in wild-type PRG-1 (wtPRG-1), nor a significant change in the mouse SNP homolog (PRG-1R346T). This was
corroborated by two mutation studies (PRG-1S347A and PRG-1S347D)
mimicking the non-phosphorylated and the constitutive phosphorylated form, which both failed to significantly take up TF-LPA pointing to the necessity of S at this position (S347). However, assessment
of O-GlcNAc glycosylation, another posttranslational modification
critical for correct brain function (Cole & Hart, 2001; Tallent et al,
2009) occurring at S and T residues and found in a reciprocal interplay with phosphorylation (Cheng & Hart, 2001), revealed significantly reduced glycosylation levels in PRG-1R346T when compared to
wtPRG-1. Interestingly, O-GlcNAC glycosylation typically occurs in
intrinsically disordered protein regions (Trinidad et al, 2012) as
present in the intracellular C-term of PRG-1 containing S347 and,
although consensus motifs of the responsible enzyme GlcNAc-b-Ser/
Thr (OGT) have not been set (Moremen et al, 2012), arginine (R)
located next to O-GlcNAC glycosylation sites was described for many
proteins (for overview see Lazarus et al, 2011). Altogether, our data
point to glycosylation as a critical mechanism for PRG-1 function,
which was significantly reduced by the PRG-1R346T SNP.
To prove that mutPRG-1 is a loss-of-function mutation also in a
neuronal context, we re-expressed the mouse homolog of the
human SNP (PRG-1R346T) in PRG-1 / mice and assessed synaptic
function using single cell electrophysiology. While it was shown
that PRG-1 reconstitution in the hippocampus restored high mEPSC
to normal levels (Trimbuch et al, 2009), PRG-1R346T re-expression,
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although correctly localized at dendritic spines, failed to do so. In
line, functional analyses of PRG-1WT- or PRG-1R346T-reconstituted
PRG-1 / neurons in terms to modulate extracellular LPA showed
that PRG-1R346T reconstitution failed to induce significant TF-LPA
uptake which was present in PRG-1WT-reconstituted neurons.
However, since (i) PRG-1R346T reconstitution did not exert a dominant-negative effect on TF-LPA uptake when expressed in WT
neurons and (ii) neurons with monoallelic PRG-1 deletion (PRG-1+/ )
displayed 50% reduction in TF-LPA uptake, which corresponds
to the halfway reduction of the PRG-1 protein in PRG-1+/ mice
(Trimbuch et al, 2009), our data show that heterozygous PRG-1
mice are a valid animal model to study synaptic alterations present
in monoallelic PRG-1WT/mut carriers.
Increased glutamate at the synapse is involved in a broad range
of diseases and alterations in cortical excitation/inhibition (E/I)
balance have been suggested to contribute to the pathophysiology
underlying mental disorders (Yizhar et al, 2011). In our present
study, we could show that control of glutamatergic transmission by
bioactive lipid signaling is an important prerequisite for proper cortical information processing. PRG-1 is highly expressed in layer IV
neurons of the somatosensory cortex and already 50% reduction of
functional active PRG-1 at the glutamatergic synapse caused
reduced LPA uptake into postsynaptic neurons, and as a consequence, shifted E/I balance toward a higher excitability of cortical
networks leading to pathological cortical information processing as
observed in schizophrenia (Coyle, 2006; Belforte et al, 2010; Hasan
et al, 2012a, 2012b; Yizhar et al, 2011). This functional impairment
leads to decreased social interaction, loss of resilience in tail suspension test after acute stress application, and decreased PPI which are
well-established animal correlates of altered mental function (Shen
et al, 2008; Inta et al, 2010). Using PRG-1+/ mice, which resemble
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the PRG-1WT/mut situation present in human SNP carriers, we could
show for the first time that proper bioactive lipid signaling at the
synapse is important for cortical information processing. This is
supported by data obtained from EEG analyses in humans showing
that P50 event-related potentials, a measure of sensory processing
and gating reflecting E/I balance alterations and impaired cortical
network function, were significantly altered in monoallelic mutPRG-1
human carriers. In sum, our study thus provides a translational line
of evidence showing that alterations in E/I balance and pre-attentive
stimulus processing, which are considered biomarkers/endophenotypes of psychiatric disorders (Coyle, 2006; Javitt et al, 2008, 2011)
and are present in PRG-1+/mut carriers, result from a reduced PRG-1
action at the synapse, leading to increased LPA levels and loss
of proper cortical network function. Our study indicates a role
of PRG-1R346T as a potential susceptibility gene for human
neuropsychiatric disorders.
Our results provide further support for the notion that cortical
excitation/inhibition imbalances contribute to glutamate-related
electrophysiological and behavioral abnormalities in psychiatric
disorders (e.g., the glutamate hypothesis of schizophrenia). Moreover, they suggest that proper bioactive lipid signaling is important
for normal sensory discrimination and learning, which both depend
on synaptic homeostatic plasticity controlling accurate E/I balance
as a prerequisite for appropriate resilience against stress-related
mental dysfunction (Kalisch et al, 2015). Thus, in addition to the
known NMDA receptor hypofunction on inhibitory neurons
(reduced feed-forward inhibition), alteration of glutamatergic activity on excitatory neurons (increased feed-forward excitation) may
contribute to psychiatric diseases (Coyle, 2006; Belforte et al, 2010;
Javitt et al, 2011; Yizhar et al, 2011).
Since modulation of the phospholipid signal cascade using LPA
synthesis inhibitors acting upstream of PRG-1 was effective in
reverting the decreased sensory gating and the altered behavior in
PRG-1+/ mice toward wild-type levels, our data provide evidence
that E/I balance critically depends on accurate regulation of synaptic
LPA levels. This synaptic regulatory mechanism seems to depend
on a proper posttranslational modification like glycosylation of the
synaptic phospholipid modulator PRG-1 and alterations in this
signaling pathway may result in altered cortical information
processing.
LPA levels are controlled by its synthesizing enzyme, autotaxin
on the one hand (Moolenaar & Perrakis, 2011), and by PRG-1 from
the postsynaptic side on the other (Trimbuch et al, 2009). Our previous studies in the hippocampus have shown that affecting this LPA
signaling pathway by additional LPA2 receptor deletion rescues the
phenotype observed in animals lacking synaptic control of bioactive
lipid signaling due to PRG-1 deficiency (Trimbuch et al, 2009). In
the present study, we show that an upstream intervention in the
LPA-LPA2/PRG-1 signaling axis (achieved by ATX inhibition)
rescued the E/I balance in the same way (reducing the higher spontaneous glutamate release and restoring sensory (double-pulse
whisker stimulation model) and sensorimotor gating (PPI) in
PRG-1+/ mice) as shown in our genetic studies using PRG-1 / //
LPA2 / deficient mice strains.
In sum, pharmacological intervention in the animal model of
mutPRG-1 via upstream manipulation of the above-described pathway using available ATX inhibitors was successful in rescuing
sensorimotor gating (PPI) at electrophysiological and behavioral
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level, known to resemble aspects of mental disorders (Swerdlow
et al, 1994; Cryan et al, 2005; Radyushkin et al, 2009). Clearly,
further in-depth prospective analysis of PRG-1+/mut carriers and
case–control studies in patient cohorts with psychiatric diseases is
needed to ultimately design novel treatment approaches based on
targeted intervention to synaptic lipid signaling. However, our data
suggest that interfering with LPA signaling via inhibitors of autotaxin might thus represent a promising strategy to treat the human
phenotype of PRG-1WT/mut or other stress-mediated behavioral
alterations and glutamate-related mental disorders (Harrison &
Weinberger, 2005; Coyle, 2006; Belforte et al, 2010; Javitt et al,
2011; Hasan et al, 2012b; Kalisch et al, 2015).

Materials and Methods
Electrophysiological and behavioral studies in mice
All experiments were conducted in mice on a C57BL/6J background
in accordance with the national laws for the use of animals in
research and with the European Communities Council Directive
86/609/EEC and approved by the local ethical committee
(Landesuntersuchungsamt Rheinland-Pfalz 23.177-07/G 10-1-010
and 23. 177-07/G 12-1-096). Experiments were designed to minimize the number of animals used. PRG-1 / mice were obtained by
genetic modification as described in Trimbuch et al (2009) and
backcrossed on a C57Bl/6J background (Jackson) for at least 10
generations. In utero electroporation, recordings in vitro and in vivo
were performed following standard protocols and are described in
more detail in the Appendix Supplementary Methods.
LPA uptake assay
HEK293 cells and HEK293 cell lines expressing wild-type PRG-1,
PRG-1R346T (corresponding to the human R345T mutation),
PRG-1S346A, and PRG-1S346D were incubated with TF-LPA [Avanti
Polar Lipids, USA (Saunders et al, 2011)] at 1 lM for 5 min at 37°C.
After removing TF-LPA from the cell surface by washing the cells
(3 × 5 min) with 0.001% SDS in DMEM, cells were assessed by flow
cytometry (FACSCanto II, Becton Dickinson, USA) and analyzed by
the FlowJo software (Tree Star, USA). TF-LPA uptake was either
calculated as changes of internalized TF-LPA when compared to
non-transfected HEK293 cells or to PRG-1-expressing cells. In
another set of experiments, cells were incubated with non-natural
lipid C17-LPA (Avanti Polar Lipids, USA) instead of TF-LPA. C17LPA and its degradation product C17-MG were subsequently
assessed by mass spectrometry. Primary neuronal cultures were
prepared and transfected according to standard procedures. TF-LPA
stimulation and optical detection of neuronal TF-LPA uptake was
performed as described in the Appendix Supplementary Methods.
Quantitative phosphorylation studies
Isotopically labeled peptides (Heavy PeptideTM AQUA QuantPro)
were purchased from Thermo Fisher Scientific (Waltham, MA). For
assessing S347 phosphorylation in wt PRG-1 and in PRG-1R346T
following heavy isotope labeled peptides were used: SLTDLNQDPS
[R(13C6;15N4)],
DALRSLTDLNQDPS[R(13C6;15N4)],
DALR[S
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(PO3H2)]LTDLNQDPS[R(13C6;15N4)], DALT[S(PO3H2)]LTDLNQD
PS[R(13C6;15N4)], and DALTSLTDLNQDPS[R(13C6;15N4)]. Proteolytic digestion and quantitative liquid chromatography–ion mobility
separation–mass spectrometry (LC-IMS-MS) was performed as
described in the Appendix Supplementary Methods.
Glycosylation studies using co-immunoprecipitation and
Western blotting
For glycosylation studies, co-IP was performed using protein G
agarose beads and a custom-made anti-PRG-1 antibody (Trimbuch
et al, 2009) according to standard procedures. Western blotting was
performed using a anti-O-GlcNAc antibody (1:1,000 dilution;
CTD110.6, Cell Signaling, USA). For quantification, membranes
were stripped and the total amount of PRG-1 was assessed using the
above-described anti-PRG-1 antibody. For details, see Appendix
Supplementary Methods.
Immunostaining
Cell labelings were performed using established antibodies and
following standard protocols. For details, see Appendix Supplementary Methods.

Across study sites, the study including recordings of EEG was
conducted according to the same standard operating procedure.
A detailed description of stimulus presentation (auditory double
click paradigm), EEG recording, and signal analysis of the P50
event-related potential (ERP) has been provided in previous publications (Brinkmeyer et al, 2011; Quednow et al, 2012). The most
widely used P50 measure is the S2/S1 ratio (Turetsky et al, 2007).
However, recent data suggest that individual S1 and S2 amplitudes
as well as the S1-S2 difference may exhibit higher heritability
(Anokhin et al, 2007) and superior test–retest reliability than the
S2/S1 ratio (Fuerst et al, 2007). In view of this lack of superiority of
one particular P50 measure over the others, statistical analyses of
prg-1 genotype effects on P50 ERP measures were performed on S1
and S2 amplitudes, S1-S2 difference, and S2/S1 ratio.
Genotyping was performed by pyrosequencing according to
manufacturer’s instructions using the PSQ 96 SNP reagent kit
(Qiagen, Hilden, Germany) on a PSQ HS96A instrument (Qiagen,
Hilden, Germany). Primer sequences and assay conditions are
available on request.
Immunocytochemistry on human tissue

All experiments were conducted in accordance with the national
laws for the use of animals in research and with the European
Communities Council Directive 86/609/EEC and were approved by
the local ethical committee (Landesuntersuchungsamt, RheinlandPfalz, Germany, #23 177-07/G 12-1-096). Social interaction, PPI,
and tail suspension test (before and after acute stress) were
conducted as described elsewhere. For details, see Appendix Supplementary Methods.

Samples from the somatosensory cortex of a human brain were
obtained from routine autopsy in accordance with local ethical
committee guidelines. The subject died of non-neurological causes.
Tissue was immersion-fixed in 4% PFA over 48 h and snap-frozen
on dry ice. Co-localization studies were performed on cryosections
using a PRG-1 antibody (custom-made antibody described and
characterized by Trimbuch et al, 2009 was used in a dilution of
1:500) and antibodies against GAD67 (1:500; mab5406, Chemicon),
NeuN (1:1,000; mab377, Chemicon), MAP2 (1:1,000; mab 3418,
Chemicon), PSD-95 (1:250, mab1569; Millipore), parvalbumin
(1:500; PV235, Swant), and calretinin (1:500; 6B3, Swant). Confocal
images were taken on a Leica SP5.

Pharmacological intervention

Statistical analysis

Animals were treated using the in vivo potent autotaxin inhibitor PF
8380 (Gierse et al, 2010). Animals received a single i.p. injection 3 h
prior to PPI. PF8380 concentration in the cerebrospinal fluid (CSF)
was measured by mass spectrometry 3 h after injection, yielding a
concentration up to 0.42 pmol/ll (with an IC50 of 0.1 pmol/ll)
(Gierse et al, 2010).

For animal experiments, mice from the same litter or of similar
age were chosen. The investigator was blinded for the genotype of
the animals. Following experiments, experimental results were
analyzed, animals were regenotyped, and corresponding final
statistical analyses were performed. Briefly, after assessing for
normal distribution (using the Kolmogorov–Smirnov test), comparison between two groups, if not otherwise stated, was performed
using a two-tailed unpaired t-test for normal distributed data or a
Mann–Whitney U-test for nonparametric data. Comparison
between more than two groups was performed using an one-way
ANOVA for parametric data or a Kruskal–Wallis test for nonparametric data. Variances were similar between groups and were
estimated using either the F-test or the Brown–Forsythe test and
the Bartlett’s test. Post hoc analysis for more than two groups for
parametric data was performed using the Bonferroni adjustment
for multiple comparisons and Dunn’s test for nonparametric data.
For behavioral analyses assessing genotype effects and treatment
effects, a 2-way ANOVA was used. Statistical analyses of data
(including testing for normality using the Kolmogorov–Smirnov
test) were performed with GraphPad Prism 5/6 (La Jolla, CA,
USA) or with SPSS (Chicago, IL, USA).

Behavioral analyses

PRG-1 genotype effect on P50 event-related potential
measures in humans
Study participants were investigated in the context of the German
multicenter study “Genetics of nicotine dependence and neurobiological phenotypes”. This study was approved by the ethics committees
of each study site’s local university and was conducted according to
the Declaration of Helsinki and informed consent was obtained from
all subjects as described in detail by Lindenberg et al (2011) and
Quednow et al (2012). Subjects were healthy as assessed by a standard medical examination, a drug screen, and routine clinical laboratory tests. They had no current psychiatric disorder according to
DSM-IV axis I as assessed by the standardized psychiatric interview
(SCID-1) and were not on any medication affecting CNS function.
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The paper explained
Problem
A mutation (PRG-1R345T) in the human PRG-1 gene with a monoallelic
frequency of ~0.6% affects 5 million European and US citizens and
results in an altered signal integration in the central nervous system.
We uncovered the underlying molecular signaling pathway at the
synapse which involves bioactive lipids controlling basal glutamatergic
release in cortical neurons. This pathway is regulated by PRG-1 which
interacts with bioactive phospholipids eventually modulating excitation and signal integration.
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Similarly, the linear mixed-effects models also are not affected by
the uneven group sizes. These analyses were performed in the
statistical environment R (Team, 2011) using the package “meta”
(version 2.1-0).
Expanded View for this article is available online.
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Results
Applying molecular, electrophysiological, and behavioral analyses in
rodents, we show that PRG-1R345T is a loss-of-function mutation, incapable of phospholipid interaction and internalization. Monoallelic loss
of PRG-1 in rodents led to loss of somatosensory filter function and
altered resilience during stress-related behaviors, which are both
regarded as an endophenotype for psychiatric disorders. Electrophysiological assessment of monoallelic human PRG-1R345T carriers revealed
a similar reduced sensory filter function.
Impact
Using pharmacological intervention into phospholipid signaling, we
were able to rescue the altered cortical somatosensory filter function
in an animal model with monoallelic PRG-1 deficiency pointing to a
new therapeutic rationale for psychiatric disorders.

For statistical analysis of human data, complete datasets including P50 ERP measures and prg-1 genotype were available from six
study centers for N = 1,811 subjects (N = 12 monoallelic carriers of
the prg-1 variant versus N = 1,799 wt/wt controls). There were no
deviations from Hardy–Weinberg equilibrium (exact test: P = 1.0).
Major and minor allele frequencies (99.669 and 0.331%, respectively) were consistent with the frequencies reported previously by
the NHLBI Exome Sequencing Project. Key sociodemographic sample
characteristics are provided in Appendix Table S1 (Lehrl, 1999).
To avoid confounders such as age, smoking, and study site on
P50 ERP measures, we performed a stratified analysis of prg-1
genotype effects. For each EEG measure, three strata were determined by predicting for each individual the expected value from a
regression model, incorporating age, smoking, and study site, and
dividing individuals into distinct, roughly equally sized strata,
based on visual inspection of the histograms of predicted values.
This model for stratum assignment mainly uses information from
the wt/wt controls to control for confounding. In a sensitivity analysis excluding the carriers from model fitting, the results did not
change. Subsequently, the standardized mean difference between
prg-1 wt/wt and monoallelic R345T carriers was determined in
each stratum and aggregated over the strata using inverse variance
weighting, as commonly used in fixed effect meta-analysis (Cooper
& Hedges, 1994). The assumption of normal distribution, required
to obtain p-values corresponding to the aggregated differences,
was checked by Q-Q plots. For the S1 and S2 combined effect, the
standardized mean difference was obtained from a linear mixedeffects model incorporating a per-subject random effect. For all
other measures, standardized mean differences were directly
obtained from mean values and standard deviations, which were
calculated separately for the carriers and wt/wt controls, that is,
the uneven size of the two groups does not skew the results.
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